Dual targeting of CD155 augments the antitumor efficacy of ROR1-CAR-T cells in ovarian cancer
Favorite
Share
More Options
17

Open in WPS to view all 17 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
